Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

A novel mutation in the FECH gene in a Czech family with erythropoietic protoporphyria and a population study of IVS3-48C variant contributing to the disease

M. S. Farrag, J. Kučerová, L. Šlachtová, O. Šeda, J. Šperl, P. Martásek

. 2015 ; 61 (6) : 227-232.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc16031530

Erythropoietic protoporphyria (EPP), a chronic erythropoietic porphyria, is characterized by excess accumulation of protoporphyrin, particularly in erythroid cells. EPP inheritance is complex, almost always associated with two molecular defects. In most EPP patients, clinical expression requires coinheritance of a private ferrochelatase (FECH) mutation trans- to a hypomorphic FECH*IVS3-48C allele. This leads to a decrease of FECH activity below the critical threshold. This is characterized by cutaneous photosensitivity in early childhood such as itching, burning, swelling and redness in sun-exposed areas. Hepatic failure occurs in some patients (about 1-10 % of EPP patients), which may necessitate liver transplantation. We investigated a Czech family with two patients with manifested EPP in four generations. We found a novel mutation, c.84G >A, in the FECH gene in four individuals including proband and his mother (G84A transition in exon 2; p.W28*). Both clinically manifested probands inherited the hypomorphic IVS3-48C allele as well, while two clinically latent individuals with FECH mutation did not. To address the question whether the relatively low incidence of EPP in the Czech Republic might be due to lower frequency of the IVS3-48C allele, we screened for the frequency of the low expression allele in a control Czech (West Slaves) Caucasian population. Such study has not been performed in any Slavic population. Among 312 control individuals, there were no IVS3-48C/C (c.68-23C-T) homozygotes; 35 IVS3-48C/T heterozygous individuals were detected. The frequency of IVS3-48C allele was thus found to be 5.5 % in the Czech population, comparable to most West Caucasian populations.

000      
00000naa a2200000 a 4500
001      
bmc16031530
003      
CZ-PrNML
005      
20230725110955.0
007      
ta
008      
161103s2015 xr d f 000 0|ENG||
009      
AR
035    __
$a (PubMed)26789144
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a ENG
044    __
$a xr
100    1_
$a Farrag, M. S. $u Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic
245    12
$a A novel mutation in the FECH gene in a Czech family with erythropoietic protoporphyria and a population study of IVS3-48C variant contributing to the disease / $c M. S. Farrag, J. Kučerová, L. Šlachtová, O. Šeda, J. Šperl, P. Martásek
520    9_
$a Erythropoietic protoporphyria (EPP), a chronic erythropoietic porphyria, is characterized by excess accumulation of protoporphyrin, particularly in erythroid cells. EPP inheritance is complex, almost always associated with two molecular defects. In most EPP patients, clinical expression requires coinheritance of a private ferrochelatase (FECH) mutation trans- to a hypomorphic FECH*IVS3-48C allele. This leads to a decrease of FECH activity below the critical threshold. This is characterized by cutaneous photosensitivity in early childhood such as itching, burning, swelling and redness in sun-exposed areas. Hepatic failure occurs in some patients (about 1-10 % of EPP patients), which may necessitate liver transplantation. We investigated a Czech family with two patients with manifested EPP in four generations. We found a novel mutation, c.84G >A, in the FECH gene in four individuals including proband and his mother (G84A transition in exon 2; p.W28*). Both clinically manifested probands inherited the hypomorphic IVS3-48C allele as well, while two clinically latent individuals with FECH mutation did not. To address the question whether the relatively low incidence of EPP in the Czech Republic might be due to lower frequency of the IVS3-48C allele, we screened for the frequency of the low expression allele in a control Czech (West Slaves) Caucasian population. Such study has not been performed in any Slavic population. Among 312 control individuals, there were no IVS3-48C/C (c.68-23C-T) homozygotes; 35 IVS3-48C/T heterozygous individuals were detected. The frequency of IVS3-48C allele was thus found to be 5.5 % in the Czech population, comparable to most West Caucasian populations.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a sekvence aminokyselin $7 D000595
650    _2
$a sekvence nukleotidů $7 D001483
650    _2
$a biosyntetické dráhy $x genetika $7 D053898
650    _2
$a DNA $x genetika $7 D004247
650    _2
$a mutační analýza DNA $7 D004252
650    _2
$a erytrocyty $x metabolismus $7 D004912
650    _2
$a rodina $7 D005190
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a ferrochelatasa $x chemie $x genetika $7 D005294
650    12
$a genetická predispozice k nemoci $7 D020022
650    _2
$a genom lidský $7 D015894
650    _2
$a hem $x biosyntéza $7 D006418
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a molekulární sekvence - údaje $7 D008969
650    _2
$a mutace $x genetika $7 D009154
650    _2
$a rodokmen $7 D010375
650    12
$a polymorfismus genetický $7 D011110
650    _2
$a erytropoetická protoporfyrie $x krev $x enzymologie $x genetika $7 D046351
650    _2
$a protoporfyriny $x krev $7 D011524
651    _7
$a Česká republika $7 D018153 $2 czmesh
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kučerová, Johana $u Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $7 _AN039215
700    1_
$a Šlachtová, Lenka $u Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $7 xx0126046
700    1_
$a Šeda, Ondřej $u Institute of Biology and Genetics, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $7 xx0070901
700    1_
$a Šperl, Jan $u Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $7 xx0071614
700    1_
$a Martásek, Pavel, $u Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $d 1952- $7 xx0077949
773    0_
$w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 61, č. 6 (2015), s. 227-232
856    41
$u http://fb.cuni.cz/ $y domovská stránka časopisu
910    __
$a ABA008 $b A 970 $c 89 $y 4 $z 0
990    __
$a 20161103 $b ABA008
991    __
$a 20230725110952 $b ABA008
999    __
$a ok $b bmc $g 1174663 $s 956196
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 61 $c 6 $d 227-232 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
LZP    __
$b NLK118 $a Pubmed-20161103

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...